ALACHUA, Fla.--(BUSINESS WIRE)--Banyan Biomarkers, Inc. announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,396,654 B2 “Neural Proteins as Biomarkers for Traumatic Brain Injury,” licensed exclusively by Banyan Biomarkers from the University of Florida. Specifically, the patent covers the detection of certain neuronal protein markers found in the blood of patients suffering from neural injury and / or neuronal damage. The patent also covers certain sensitive and rapid methods and test kits that can be used as tools for the diagnosis of neural injuries and/or neuronal disorders such as brain injury, neural damage due to drug or alcohol addiction and diseases associated with the brain and central nervous system.
